3 unchanged sentences
In 2023, the Board of Directors approved a 36-month extension to the share repurchase program through June 30, 2026.
−Removed: As of March 31, 2025, the Company had $150.7 million available under the program.
+Added: On June 12, 2025, the Company announced an increase of $100.0 million in the Company’s share repurchase program along with a one-year extension through June 30, 2027.
+Added: As of June 30, 2025, the Company had $250.7 million available under the program.
The repurchases may be made either in the open market or through private transactions, including repurchases made pursuant to a plan intended to comply with Rule 10b5-1 under the Exchange Act, subject to market conditions, applicable legal requirements, and other relevant factors.
The Company has no obligation to repurchase shares and the share repurchase program may be suspended or discontinued by the Company at any time.
−Removed: During the three months ended March 31, 2025, the Company did not repurchase any common shares under the Company’s publicly announced program, and there are no other programs under which the Company repurchases shares.
−Removed: The Company’s common share repurchase program activity for the three months ended March 31, 2025 was as follows:
+Added: During the three months ended June 30, 2025, the Company did not repurchase any common shares under the Company’s publicly announced program, and there are no other programs under which the Company repurchases shares.
+Added: The Company’s common share repurchase program activity for the three months ended June 30, 2025 was as follows:
Total number of shares purchased
2 unchanged sentences
Maximum approximate dollar value of shares that may yet be purchased under the program
−Removed: January 1 through January 31, 2025
+Added: April 1 through April 30, 2025
— $ — — $ 150,720,352
−Removed: February 1 through February 28, 2025
+Added: May 1 through May 31, 2025
— — — 150,720,352
−Removed: March 1 through March 31, 2025
+Added: June 1 through June 30, 2025 (1)
— — — 250,720,352
Total — $ — —
+Added: (1) On June 12, 2025, the Company announced an increase of $100.0 million in the Company’s share repurchase program.
In 2024, IMAX China’s shareholders granted its Board of Directors a general mandate authorizing the Board of Directors of IMAX China, subject to applicable laws, to repurchase shares of IMAX China not to exceed 10% of the total number of issued shares as of June 7, 2024 (34,000,845 shares).
This program expired on the date of the 2025 Annual General Meeting of IMAX China on June 12, 2025.
−Removed: During the 2024 Annual General Meeting of IMAX China, shareholders approved the repurchase of shares of IMAX China not to exceed 10% of the total number of shares as of June 7, 2024 (34,000,845 shares).
+Added: During the 2025 Annual General Meeting of IMAX China, shareholders granted its Board of Directors a general mandate authorizing the Board of Directors of IMAX China, subject to applicable laws, to repurchase shares of IMAX China not to exceed 10% of the total number of shares as of June 12, 2025 (33,919,122 shares).
This program will be valid until the 2026 Annual General Meeting of IMAX China.
1 unchanged sentence
IMAX China has no obligation to repurchase its shares and the share repurchase program may be suspended or discontinued by IMAX China at any time.
−Removed: During the three months ended March 31, 2025, IMAX China did not repurchase any shares.
+Added: During the three months ended June 30, 2025, IMAX China repurchased 1,495,900 shares.
(Refer to Note 6 of Notes to Condensed Consolidated Financial Statements in Part I, Item 1 for a summary of the material terms and conditions of the Company’s revolving credit facility, which include a limitation of the amount of permitted share repurchases.)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.